Free Trial
→ $100 Trillion “AI Metal” Found in American Ghost Town (From Brownstone Research) (Ad) Free ENLV Stock Alerts

Enlivex Therapeutics (ENLV) SEC Filings & 10K Form

Enlivex Therapeutics logo
$1.18 +0.05 (+3.98%)
Closing price 07/3/2025 02:39 PM Eastern
Extended Trading
$1.18 0.00 (0.00%)
As of 07/3/2025 04:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Enlivex Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
05/15/2025
2:27 PM		ARMISTICE CAPITAL, LLC (Filed by)
Enlivex Therapeutics Ltd. (Subject)
Enlivex Therapeutics (Subject)
Form SCHEDULE 13G/A
05/12/2025
11:15 PM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form EFFECT
05/02/2025
4:11 PM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
04/23/2025
7:32 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/21/2025
7:32 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/03/2025
7:02 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/17/2025
7:02 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/03/2025
7:23 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2025
5:22 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2025
4:43 PM		ARMISTICE CAPITAL, LLC (Filed by)
Enlivex Therapeutics Ltd. (Subject)
Enlivex Therapeutics (Subject)
Form SCHEDULE 13G/A
12/11/2024
7:33 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/03/2024
7:32 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/29/2024
3:30 PM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/20/2024
7:02 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
7:01 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/31/2024
3:05 PM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/30/2024
7:01 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
5:03 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K/A
09/26/2024
7:32 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/24/2024
7:33 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/11/2024
7:30 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/23/2024
7:02 AM		Enlivex Therapeutics Ltd. (Filer)
Enlivex Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:ENLV) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners
Banks aren’t ready for this altcoin—are you?
Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...
Crypto 101 Media | Sponsored
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...
American Alternative | Sponsored
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...
Paradigm Press | Sponsored
Trump’s New Order Could Boost Social Security Benefits by 400%
If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...
InvestorPlace | Sponsored
Post-Halving = Profit Season (Here’s How to Win It)
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...
Crypto Swap Profits | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...
Brownstone Research | Sponsored
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsored